QTLs in Region (GRCr8)
2313090 | Bmd69 | Bone mineral density QTL 69 | 4.4 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 5293229 | 34184556 | Rat |
631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 7746118 | 52746118 | Rat |
4889451 | Eae29 | Experimental allergic encephalomyelitis QTL 29 | 5.51 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis severity score (CMO:0001419) | 1 | 7746121 | 52746121 | Rat |
70179 | Xhs2 | X-ray hypersensitivity QTL 2 | 3.2 | | intestine integrity trait (VT:0010554) | post-insult time to onset of moribundity (CMO:0001896) | 1 | 1 | 43965634 | Rat |
1558642 | Prcr2 | Prostate cancer resistance QTL 2 | 4.3 | | prostate integrity trait (VT:0010571) | area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) | 1 | 10379492 | 55379492 | Rat |
7421626 | Bp360 | Blood pressure QTL 360 | | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 6941022 | 51941022 | Rat |
2313070 | Bss52 | Bone structure and strength QTL 52 | 4.4 | 0.0001 | body length (VT:0001256) | body length (CMO:0000013) | 1 | 5293229 | 34184556 | Rat |
1357401 | Bw43 | Body weight QTL 43 | 3.75 | | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 6909353 | 51909353 | Rat |
631494 | Bp95 | Blood pressure QTL 95 | 40 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 17315378 | 51816258 | Rat |
5684998 | Bss101 | Bone structure and strength QTL 101 | 3.6 | | tibia strength trait (VT:1000284) | tibia ultimate force (CMO:0001734) | 1 | 6909353 | 51909353 | Rat |
5684999 | Bss102 | Bone structure and strength QTL 102 | 5.5 | 7e-07 | tibia strength trait (VT:1000284) | tibia stiffness (CMO:0001735) | 1 | 6909353 | 51909353 | Rat |
2302038 | Pia31 | Pristane induced arthritis QTL 31 | 5.5 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) | 1 | 12820494 | 57820494 | Rat |
2317755 | Glom22 | Glomerulus QTL 22 | 3.8 | | urine protein amount (VT:0005160) | urine protein level (CMO:0000591) | 1 | 1 | 34184556 | Rat |
634353 | Rends2 | Renal damage susceptibility QTL 2 | | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 1 | 20656420 | 65656420 | Rat |
1300170 | Rf6 | Renal function QTL 6 | 3.14 | | renal blood flow trait (VT:2000006) | absolute change in renal blood flow rate (CMO:0001168) | 1 | 1 | 28483164 | Rat |
1578756 | Iddm22 | Insulin dependent diabetes mellitus QTL 22 | 2.7 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 20508326 | 65508326 | Rat |
631508 | Sald1 | Serum aldosterone level QTL 1 | 3.7 | | blood aldosterone amount (VT:0005346) | serum aldosterone level (CMO:0000487) | 1 | 11684464 | 56684464 | Rat |
2313053 | Bss51 | Bone structure and strength QTL 51 | 3.8 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 5293229 | 34184556 | Rat |